Product Overview

Artesunate Injection IP 120 mg is an injectable antimalarial formulation designed for the management of severe malaria. Artesunate acts rapidly against blood-stage malaria parasites and helps reduce parasite levels in the bloodstream.

After administration, Artesunate is rapidly converted to dihydroartemisinin, its active metabolite. This provides potent activity against susceptible Plasmodium parasites and makes injectable Artesunate an important treatment option when rapid antimalarial action is required.

The formulation can be administered intravenously or intramuscularly by qualified healthcare professionals. Injectable treatment is generally followed by an appropriate complete antimalarial regimen according to clinical guidelines and the treating physician’s recommendation.

Key Features

• Rapid-acting injectable antimalarial
• Supports severe malaria treatment
• Suitable for IV or IM administration
• Helps rapidly reduce malaria parasite levels
• Designed for hospital and clinical use

Uses

• Severe malaria
• Injectable treatment of malaria
• Malaria requiring rapid parenteral therapy

How It Works

Artesunate is converted into active dihydroartemisinin, which acts on blood-stage malaria parasites and helps rapidly reduce the parasite burden.

Possible Side Effects

• Nausea
• Vomiting
• Headache
• Dizziness
• Injection-site reactions
• Changes in blood counts

Precautions

• Use only under medical supervision
• Administer only by qualified healthcare professionals
• Appropriate monitoring is required
• Complete follow-up antimalarial therapy as prescribed
• Not intended for self-administration

Storage Instructions

Store in a cool, dry place protected from light and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.